CoChat
Sign Up
Cited by 147Sexual Differentiation and DisordersAdrenal Hormones and DisordersMetabolism and Genetic Disorders

Congenital lipoid adrenal hyperplasia: the human gene knockout for the steroidogenic acute regulatory protein

Miller, WL·1997·Journal of Molecular Endocrinology
DOI 10.1677/jme.0.0190227
Open this paper in CoChat — free account

Abstract

Lipoid CAH was first described in detail as an inherited endocrine disorder by Prader and colleagues (Prader & Gurtner 1955, Prader & Siebenmann 1957, Prader & Anders 1962), although at least four autopsy cases appeared earlier in the pathology literature (Tilp 1913, Brutschy 1920, Zahn 1948, Sandison 1955). Prader’s group described male pseudohermaphroditism, an apparent lack of adrenal steroids and accumulation of lipid deposits in the adrenal, inherited in an autosomal recessive fashion. Written in German, Prader’s work was not widely recognized until Camacho et al. (1968) reported an apparently milder case, with the onset of clinically apparent salt loss at 8 months of age, and postulated that the disorder was in one of the enzymes involved in the conversion of cholesterol to pregnenolone. However, the nature of the defect was unclear, in part because the enzymology of the conversion of cholesterol to pregnenolone was unclear. At that time it was thought that the conversion of cholesterol to pregnenolone required at least three enzymes, a 20a-hydroxylase, a 22-hydroxylase, and a 20,22 desmolase (Shimizu et al. 1961), and that lipoid CAH was due to a defect in one of these enzymes. Degenhart et al. (1972) were the first to study lipoid CAH in vitro, by comparing the production of pregnenolone by mitochondria from the adrenals of affected and unaffected infants. Mitochondria from affected tissue could not convert cholesterol to pregnenolone (although normal mitochondria could), but affected mitochondria could convert 20a-hydroxycholesterol to pregnenolone. They logically concluded that the defect was in a specific 20a-hydroxylase; this conclusion was incorrect, but the experimental design was prescient: 23 years later we used a similar experiment to prove that lipoid CAH was due to a mutation in a non-enzymatic protein (Lin et al. 1995). Koizumi et al. (1977) also found that affected mitochondria failed to convert cholesterol to pregnenolone but were unable to account for Degenhart’s findings. By this time it was clear that the conversion of cholesterol to pregnenolone was catalyzed by a mitochondrial cytochrome P450 enzyme, termed P450scc, (where scc denotes side chain cleavage), which functions as the terminal oxidase in a mitochondrial electron-transfer chain where NADPH donated electrons to a flavoprotein (adrenodoxin reductase) which then transferred them to an iron-sulfur protein (adrenodoxin) which in turn donated them to P450scc (Kimura & Suzuki 1965, Omura et al. 1966, Shikita & Hall 1973) (for review see Miller 1988). Thus Koizumi examined the total P450 in the affected adrenal mitochondria in the only fashion then available, by carbon monoxide-induced difference spectra, and concluded that affected mitochondria had roughly half of the normal amount of total cytochrome P450. At that time it was known that steroid 11â-hydroxylase and 18-hydroxylase activities were also catalyzed by a mitochondrial P450, and as the affected mitochondria had normal 11â-/18-hydroxylase activity but failed to convert cholesterol to pregnenolone, Koizumi et al. (1977) logically concluded that the 227

Integrity signals

Registry

Crossref · 10.1677/jme.0.0190227

Cites

70 of 70 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • P450scc (CYP11A1) plays an essential role converting cholesterol to pregnenolone.

    “The cholesterol side-chain cleavage enzyme, P450scc (CYP11A1), plays an essential role converting cholesterol to pregnenolone.”

    From Congenital lipoid adrenal hyperplasia (2014) · cites this paper as [1]

  • Lipoid CAH has been reported in most ethnic groups but is common among the Japanese, Korean, and Palestinian Arab populations.

    “Lipoid CAH has been reported in most ethnic groups but is common among the Japanese, Korean, and Palestinian Arab populations1,3,4,10,11,13,29,30,31,32).”

    From Congenital lipoid adrenal hyperplasia (2014) · cites this paper as [1]

  • Lipoid CAH is common in Japan and Korea.

    “Lipoid CAH is the most fatal form of CAH and is common in Japan and Korea.”

    From Congenital lipoid adrenal hyperplasia (2014) · cites this paper as [1]

  • Lipoid CAH is the most fatal form of CAH and disrupts adrenal and gonadal steroidogenesis by a defect in the conversion of cholesterol to pregnenolone.

    “Congenital lipoid adrenal hyperplasia (lipoid CAH) is the most fatal form of CAH, as it disrupts adrenal and gonadal steroidogenesis.”

    From Congenital lipoid adrenal hyperplasia (2014) · cites this paper as [1]

  • Cholesterol is the precursor for steroidogenesis and the initial rate-limiting step is conversion of cholesterol to pregnenolone.

    “Cholesterol is the precursor for steroidogenesis and the initial rate-limiting step is the conversion of cholesterol to pregnenolone1).”

    From Congenital lipoid adrenal hyperplasia (2014) · cites this paper as [1]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Related

Authors
Miller, W.
Venue
Journal of Molecular Endocrinology
Publisher
Bioscientifica
Published
1997-12-01
Volume
19
Issue
3
Pages
227-240
ISSN
  • 0952-5041 (ISSN-L)
  • 1479-6813
DOI
10.1677/jme.0.0190227
OpenAlex
W2117423855
Cited by
147
References
70
Citations by year
2026: 5 · 2025: 1 · 2024: 1 · 2023: 2 · 2022: 7 · 2021: 4 · 2020: 4 · 2019: 3 · 2018: 3 · 2017: 2 · 2016: 3 · 2015: 3 · 2014: 7 · 2013: 5 · 2012: 3
FWCI
2.84
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Molecular Endocrinology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5r01dk042154-09)
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK-37922, DK 42154, R01DK037922)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD-34449, U54HD034449)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sexual Differentiation and Disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
Keywords
steroidogenic acute regulatory protein, SRD5A1, gene knockout, mitochondrial steroidogenesis, autosomal recessive inheritance
MeSH terms
Steroidogenic Acute Regulatory Protein, Adrenal Hyperplasia, Congenital, Animals, Genes, Humans, Mutation, Phosphoproteins, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review